Category - Markets

Markets

Piper starts Adagio at overweight; PT $3

Piper Sandler initiated coverage of Adagio Medical Holdings (NASDAQ: ADGM) with an “overweight” rating and price target of $3.00. The stock closed at $1.33 on April 13th. Adagio is a pre-commercial medtech company that...

April 14, 2026

Markets

Stifel starts Tectonic Therapeutic at buy; PT $75

Stifel initiated coverage of Tectonic Therapeutic (NASDAQ:TECX) with a “buy” rating and price target of $75.00. The stock closed at $29.96 on April 13. Tectonic is a clinical-stage biotech, developing therapies...

April 13, 2026

Markets

Clear Street upgrades Korro Bio to buy; PT to $18.00 from $10.00

Clear Street upgraded Korro Bio (NASDAQ: KRRO) to “buy” from “hold” and raised its price target to $18.00 from $10.00, following Korro’s late January Analyst Day detailing their new lead program, KRRO-121 for...

February 18, 2026

Markets

Lake Street sees CMS’s proposed 2026 TULSA reimbursement as favorable

Lake Street Capital Markets senior research analyst, Ben Haynor, issued a research note today on Profound Medical (NASDAQ:PROF; TSX:PRN), reiterating his ‘buy’ rating and $11 target price on the company’s stock...

July 16, 2025

Markets

Light AI goes public on CBOE Canada, stock rallies on first day of trading

Light AI (CBOE CA: ALGO) announced the completion of its IPO (including the agents’ full exercise of their over-allotment option) and began trading on CBOE Canada today. Including the units sold pursuant to the over...

January 8, 2025

Markets

Lake Street analyst pitches Profound Medical as one of his ‘best ideas’ for 2025

Lake Street Capital Markets senior research analyst, Ben Haynor, issued a research note today on Profound Medical (NASDAQ:PROF; TSX:PRN), reiterating his ‘buy’ rating and $17 target price on the company’s stock...

January 2, 2025

Markets

Clear Street initiates coverage of several healthcare stocks

Analysts Kaveri Pohlman, PhD and Bill Maughan, PhD from Clear Street, a cloud-native financial technology firm on a mission to modernize the brokerage ecosystem, have launched coverage of several healthcare names. “The...

December 11, 2024

Markets

Leede Financial starts Nanalysis Scientific at buy; PT C$0.90

Leede Financial launched coverage of Nanalysis Scientific (TSXV: NSCI) (OTCQX: NSCIF) with a “speculative buy” rating and C$0.90 target price. The stock closed at $0.365 on November 22. Nanalysis operates two distinct...

November 25, 2024

Markets

Capricor prices common stock offering

Capricor Therapeutics (NASDAQ:CAPR) has priced a public offering of 4,412,000 common shares at a price of $17.00 per share. Capricor also granted underwriters a 30-day option to purchase up to an additional 661,800...

October 17, 2024

Markets

BTIG starts Definitive Healthcare at buy; PT $7

BTIG launched coverage of Definitive Healthcare (NASDAQ:DH) with a “buy” rating and $7 target price. The stock closed at $4.44 on September 16. Definitive Healthcare is one of the industry’s most comprehensive...

September 18, 2024

Category - Markets

Subscribe